We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gold Nanoparticles Kill Cancer Cells by Stopping Cell Division

By LabMedica International staff writers
Posted on 03 Mar 2010
Gold nanoparticles that penetrate the nucleus of cancer cells damage the DNA, prevent the cells from completing the process of cell division, and lead to programmed death (apoptosis) of the cells. More...


Investigators from the Georgia Institute of Technology (Atlanta, USA; www.gatech.edu) had previously shown that gold nanoparticles could be introduced into cancer cells, and after having been stimulated by laser light destroy them. In the current study, they have developed a solution for treating cancer cells that could not be reached by laser light.

The researchers reported in the February 19, 2010, online edition of the Journal of the American Chemical Society (JACS) that by labeling the gold nanoparticles with the appropriate peptides, they could be directed to first the cytoplasm and then the nucleus of cancer cells. The cancer cells, which had been isolated from ear, nose, and throat cancers, were growing in tissue culture.

"Previously, we have shown that we can bring gold nanoparticles into cancer cells and by shining a light on them, can kill the cells. Now we have shown that if we direct those gold nanoparticles into the nucleus, we can kill the cancer cells that are in spots we cannot hit with the light,” explained senior author Dr. Mostafa El-Sayed, professor of chemistry at the Georgia Institute of Technology. "We have developed a system that can kill cancer cells by shining light on gold nanoparticles, but what if the cancer is in a place where we cannot shine light on it? To fix that problem, we have decorated the gold with a chemical that brings it inside the nucleus of the cancer cell and stops it from dividing. The gold works by interfering with the cells' DNA. The cell starts dividing and then it collapses. Once you have a cell with two nuclei, it dies.”

Related Links:

Georgia Institute of Technology




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.